MCID: PRG001
MIFTS: 35

Progressive Muscular Atrophy malady

Categories: Neuronal diseases, Rare diseases, Muscle diseases, Bone diseases

Aliases & Classifications for Progressive Muscular Atrophy

About this section

Aliases & Descriptions for Progressive Muscular Atrophy:

Name: Progressive Muscular Atrophy 10 47 12 51 65
Progressive Spinal Muscular Atrophy 10
 
Pure Progressive Muscular Atrophy 10
Pma 51

Classifications:



External Ids:

Disease Ontology10 DOID:318
ICD1027 G12.21
ICD9CM29 335.21
SNOMED-CT59 88923002
MeSH36 D009134
NCIt42 C85027
Orphanet51 454706
UMLS65 C0917981

Summaries for Progressive Muscular Atrophy

About this section
Wikipedia:68 Progressive muscular atrophy (PMA), also known as Duchenne-Aran muscular atrophy and by various other... more...

MalaCards based summary: Progressive Muscular Atrophy, also known as progressive spinal muscular atrophy, is related to adult progressive spinal muscular atrophy aran duchenne type and spinal muscular atrophy. An important gene associated with Progressive Muscular Atrophy is TRPV4 (Transient Receptor Potential Cation Channel Subfamily V Member 4). Affiliated tissues include testes, liver and skeletal muscle, and related mouse phenotypes are respiratory system and no phenotypic analysis.

Related Diseases for Progressive Muscular Atrophy

About this section

Diseases in the Muscular Atrophy family:

progressive muscular atrophy

Diseases related to Progressive Muscular Atrophy via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 129)
idRelated DiseaseScoreTop Affiliating Genes
1adult progressive spinal muscular atrophy aran duchenne type12.6
2spinal muscular atrophy11.6
3spinal atrophy ophthalmoplegia pyramidal syndrome11.6
4charcot-marie-tooth disease11.5
5spinal muscular atrophy-111.4
6myopathy, distal, tateyama type10.3
7spinal muscular atrophy, distal, congenital nonprogressive10.3
8motor neuron disease10.3
9arthritis10.2
10melanoma10.2
11megalencephaly-polymicrogyria-postaxial polydactyly-hydrocephalus syndrome10.2SMN1, SMN2
12proximal spinal muscular atrophy type 210.2SMN1, SMN2
13regional odontodysplasia10.2SMN1, SMN2
14sandhoff disease, infantile, juvenile, and adult forms10.2SMN1, SMN2
15congenital stationary night blindness10.1SMN1, SMN2
16breast cancer10.1
17leukemia10.1
18pancreatitis10.1
19pneumonia10.1
20acquired immunodeficiency syndrome10.1
21meningitis10.1
22aneurysm10.1
23complex partial epilepsy10.1SMN1, SMN2
24body dysmorphic disorder10.1SMN1, SMN2
25spinal muscular atrophy-310.1SMN1, SMN2
26prurigo nodularis10.1SMN1, SMN2
27spinal muscular atrophy-410.1SMN1, SMN2
28williams-beuren syndrome10.1
29exotropia10.1
30mitral valve disease10.1
31spta1-related spherocytosis10.0SMN1, SMN2
32colorectal cancer10.0
33hepatocellular carcinoma10.0
34asthma10.0
35obesity10.0
36psoriatic arthritis10.0
37tetralogy of fallot10.0
38anorexia nervosa10.0
39pancreatic cancer10.0
40dermatofibrosarcoma protuberans10.0
41premature ovarian failure10.0
42fabry disease10.0
43acute leukemia10.0
44alopecia10.0
45hemophagocytic lymphohistiocytosis10.0
46pemphigus vulgaris10.0
47laryngotracheitis10.0
48lymphoma10.0
49colitis10.0
50collagenous colitis10.0

Graphical network of the top 20 diseases related to Progressive Muscular Atrophy:



Diseases related to progressive muscular atrophy

Symptoms for Progressive Muscular Atrophy

About this section

Drugs & Therapeutics for Progressive Muscular Atrophy

About this section

Drugs for Progressive Muscular Atrophy (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 89)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
MethyltestosteroneapprovedPhase 4, Phase 247458-18-46010
Synonyms:
17(alpha)-Methyl-delta(4)-androsten-17(beta)-ol-3-one
17-Methyltestosterone
17-beta-Hydroxy-17-methylandrost-4-en-3-one
17-methyltestosterone
17alpha-Methyl-3-oxo-4-androsten-17beta-ol
17alpha-Methyl-delta(4)-androsten-17beta-ol-3-one
17alpha-Methyltestosterone
17alpha-methyl-delta-androsten-17beta-ol-3-one
17alpha-methyltestosterone
17beta-Hydroxy-17-methylandrost-4-en-3-one
 
17α-methyl-Δ4-androsten-17β-ol-3-one
17α-methyltestosterone
4-Androstene-17alpha-methyl-17beta-ol-3-one
Android
Methitest
Methyltestosterone
Methyltestosteronum
Metiltestosterona
NSC-9701
Testred
Testred C-III
Virilon
2
Testosteroneapproved, investigationalPhase 4, Phase 247458-22-06013
Synonyms:
(+)-testosterone
(+-)-8-iso-testosterone
(+-)-retrotestosterone
(+-)-testosterone
(17b)-17-hydroxy-androst-4-en-3-one
(17beta)-17-Hydroxyandrost-4-en-3-one
(8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one
13-Iso-testosterone
17-Hydroxy-(17-beta)-androst-4-en-3-one
17-Hydroxy-(17beta)-androst-4-en-3-one
17-Hydroxy-10,13-dimethyl-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-cyclopenta[a]phenanthren-3-one
17-Hydroxy-D4-androsten-3-one
17-Hydroxy-androst-4-en-3-one
17-beta-Hydroxy-delta(sup 4)-androsten-3-one
17-beta-Hydroxyandrost-4-en-3-one
17?-Hydroxy-4-androsten-3-one
17a-Hydroxy-(13a)-androst-4-en-3-one
17a-Hydroxy-13a-androst-4-en-3-one
17a-Hydroxy-14b-androst-4-en-3-one
17a-Hydroxy-androst-4-en-3-one
17b-Hydroxy-(10a)-androst-4-en-3-one
17b-Hydroxy-(13a)-androst-4-en-3-one
17b-Hydroxy-(8a)-androst-4-en-3-one
17b-Hydroxy-(8a,10a)-androst-4-en-3-one
17b-Hydroxy-(9b)-androst-4-en-3-one
17b-Hydroxy-(9b,10a)-androst-4-en-3-one
17b-Hydroxy-13a-androst-4-en-3-one
17b-Hydroxy-8a-androst-4-en-3-one
17b-Hydroxy-D4-androsten-3-one
17b-Hydroxy-androst-4-en-3-on
17b-Hydroxy-androst-4-en-3-one
17b-Hydroxyandrost-4-en-3-one
17b-Hydroxyandrost-4-ene-3-one
17b-Testosterone
17b-hydroxy-4-androsten-3-one
17beta-Hydroxy-3-oxo-4-androstene
17beta-Hydroxy-4-androsten-3-one
17beta-Hydroxy-delta(sup4)-androsten-3-one
17beta-Hydroxyandrost-4-en-3-one
17beta-Hydroxyandrost-4-ene-3-one
17beta-hydroxy-4-androsten-3-one
4-Androsten-17?-ol-3-one
4-Androsten-17beta-ol-3-one
4-Androsten-3-one-17b-ol
4-androsten-17β-ol-3-one
4-androstene-17beta-ol-3-one
46923_FLUKA
46923_RIEDEL
58-22-0
7-beta-Hydroxyandrost-4-en-3-one
8-Iso-testosterone
9b,10a-Testosterone
9b-Testosterone
AA 2500
AC-14899
AC1L1LM0
Andriol
Andro
Andro 100
Andro L.A. 200
AndroGel
Androderm
Androderm (TN)
Androgel
Androgel (TN)
Android 10
Android 25
Android 5
Androlin
Andronaq
Andronate 100
Andronate 200
Andropatch
Andropository 200
Androsorb
Androst-4-en-17b-ol-3-one
Androst-4-en-17beta-ol-3-one
Androst-4-ene-17b-ol-3-one
Andrusol
Andryl 200
Aveed
Axiron
B5DEE83F-632B-48A1-A0ED-A51E7F13DF2E
BIDD:ER0555
BIM-0061761.0001
Beta Testosterone
Bio-0678
Bio-T-Gel
C00535
CCRIS 574
CDB 111C
CHEBI:17347
CHEMBL386630
CID6013
CMC_13449
COL 1621
CP 601B
CPD000058344
Cristerona T
Cristerone T
D00075
D4-Androsten-17b-ol-3-one
DB00624
Dea No. 4000
Delatest
Delatestryl
Depo-Testadiol
Depo-Testosterone
Depo-Testosterone Cypionate
Depo-testosterone
Depotest
EINECS 200-370-5
Epitestosteron
Everone 200
Fortesta
Geno-Cristaux Gremy
Geno-cristaux Gremy
Geno-cristaux gremy
HMS2052N11
HSDB 3398
Halotensin
Homosteron
Homosterone
Intrinsa
 
LMST02020002
LS-148813
LibiGel
Libigel
Lumitestosteron
MLS000563091
MLS001032098
MLS001306401
MLS002174283
Malerone
Malestrone
Malestrone (amps)
Malogen in Oil
Malogen, Aquaspension Injection
Malogen, aquaspension injection
Mertestate
Metandren
Methyltestosterone
MolPort-002-506-901
NCGC00091018-01
NSC 9700
Natesto nasal gel
Neo-Hombreol F
Neo-Testis
Neo-testis
Neotestis
Oreton
Oreton F
Oreton Methyl
Oreton-F
Orquisteron
Perandren
Percutacrine Androgenique
Percutacrine androgenique
Primotest
Primoteston
Rac-17b-hydroxy-(13a)androst-4-en-3-one
Rac-17b-hydroxy-(8a)-androst-4-en-3-one
Rac-17b-hydroxy-(9b,10a)androst-4-en-3-one
Rac-17b-hydroxy-androst-4-en-3-one
Relibra
Retrotestosterone
S00309
S2033_Selleck
SAM001246921
SMR000058344
SMR001261453
Scheinpharm Testone-Cyp
Striant
Striant (TN)
Sustanon
Sustanone
Sustason 250
Synandrol F
T-Cypionate
T1500_SIGMA
T5411_FLUKA
T5411_SIGMA
TES
Teslen
Testamone 100
Testandrone
Testaqua
Testiculosterone
Testim
Testim (TN)
Testobase
Testoderm
Testoderm Tts
Testogel
Testoject-50
Testolent
Testolin
Testopel
Testopel Pellets
Testopropon
Testosteroid
Testosteron
Testosterona
Testosterona [INN-Spanish]
Testosterone
Testosterone (JAN/USP)
Testosterone Cypionate
Testosterone Enanthate
Testosterone Gel
Testosterone Heptanoate
Testosterone Hydrate
Testosterone Propionate
Testosterone Undecanoate
Testosterone [Androgenic steroids, anabolic]
Testosterone [INN:BAN]
Testosterone and its esters
Testosterone hydrate
Testosterone solution
Testosteronum
Testosteronum [INN-Latin]
Testostosterone
Testostérone
Testoviron
Testoviron Schering
Testoviron T
Testoxyl
Testred
Testred Cypionate 200
Testrin-P.A
Testro AQ
Testro Aq
Testrone
Testryl
Tostrelle
Tostrex
Trans-Testosterone
UNII-3XMK78S47O
Viatrel
Virilon
Virilon IM
Virormone
Virosterone
Vogelxo
ZINC06500184
beta testosterone
delta(sup 4)-Androsten-17(beta)-ol-3-one
delta4-Androsten-17beta-ol-3-one
delta4-androsten-17b-ol-3-one
testosterone
trans-Testosterone
3Testosterone 17 beta-cypionatePhase 4, Phase 2474
4Testosterone undecanoatePhase 4, Phase 2474
5Anabolic AgentsPhase 4, Phase 2375
6
Testosterone enanthatePhase 4, Phase 2474315-37-79416
Synonyms:
17-((1-Oxoheptyl)oxy)androst-4-en-3-one
17-Hydroxyandrost-4-en-3-one, 17-heptanoate
17-Hydroxyandrost-4-en-3-one, 17-heptanoic acid
17beta-Enanthoxyandrost-4-en-3-one
17beta-Hydroxyandrost-4-en-3-one enanthate
4-Androsten-17beta-ol-3-one 17-enanthate
4-Androsten-3-one 17beta-enanthate
Androgyn L.A.
Andropository
Androtardyl
Atlatest
DEA No. 4000
DePatestrye
Delatest
Delatestryl
Depo-Testro Med
Ditate
Durathate
Everone
 
Exten test
Malogen L.A.
Malogen L.A.200
Orquisteron-E
Primotestone
Reposo TMD
Testanthate
Testate
Testenate
Testinon
Testoenant
Testonenant
Testosterone 17-enanthate
Testosterone 17beta-heptanoate
Testosterone 17beta-heptanoic acid
Testosterone enantate
Testosterone heptoate
Testosterone heptoic acid
Testosterone heptylate
Testosterone oenanthate
Testostroval
7Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 4, Phase 2, Phase 19988
8Antineoplastic Agents, HormonalPhase 4, Phase 24256
9AndrogensPhase 4, Phase 21162
10HormonesPhase 4, Phase 2, Phase 111748
11Hormone AntagonistsPhase 4, Phase 2, Phase 110002
12
Valproic Acidapproved, investigationalPhase 3, Phase 1, Phase 231199-66-13121
Synonyms:
(N-C3H7)2CHCOOH
(S)-2-propyl-4-pentanoate
(S)-2-propyl-4-pentanoic acid
2 PP (base)
2-N-Propyl-N-valeric acid
2-PROPYL-pentanoic acid
2-Propyl-Pentanoate
2-Propyl-Pentanoic acid
2-Propylpentanoate
2-Propylpentanoic Acid
2-Propylpentanoic acid
2-Propylvaleric Acid
2-Propylvaleric acid
2-n-Propyl-n-valeric acid
2-n-propyl-n-valeric acid
2-propylvaleric acid
4-Heptanecarboxylic acid
4-heptanecarboxylic acid
76584-70-8 (hydrochloride salt (2:1))
99-66-1
AC1L1F7T
AC1Q2ULA
AI3-10500
APO-divalproex
Abbott 44090
Acide valproique
Acide valproique [INN-French]
Acide valproique [inn-french]
Acido valproico
Acido valproico [INN-Spanish]
Acido valproico [inn-spanish]
Acidum valproicum
Acidum valproicum [INN-Latin]
Acidum valproicum [inn-latin]
Alti-Valproic
Alti-valproic
Apo-valproic
Apo-valproic syrup
Avugane
BIDD:GT0858
BRN 1750447
Baceca
C07185
CHEBI:39867
CHEMBL109
CID3121
CPD000499581
Convulex
Convulsofin
D00399
DB00313
DOM-divalproex
DOM-valproic
DOM-valproic acid E.C.
DPA
Delepsine
Depacon
Depakene
Depakene (TN)
Depakin
Depakin chrono
Depakine
Depakine chrono
Depakote
Depakote (TM)
Depakote ER
Deproic
Di-N-propylacetic acid
Di-N-propylessigsaeure
Di-N-propylessigsaure
Di-N-propylessigsaure [german]
Di-n-propylacetic acid
Di-n-propylessigsaeure
Di-n-propylessigsaure
Di-n-propylessigsaure [German]
Di-n-propylessigsäure
Dipropyl Acetate
Dipropylacetate
Dipropylacetic acid
DivK1c_000273
Divalproex
Dom-Valproic
Dom-valproate
Dom-valproic acid
Dom-valproic acid syrup
EINECS 202-777-3
Epiject I.V.
Epilex
Epilim
Epival
Epival er
Ergenyl
G2M-777
Gen-divalproex
HMS2089J06
HSDB 3582
I04-0211
InChI=1/C8H16O2/c1-3-5-7(6-4-2)8(9)10/h7H,3-6H2,1-2H3,(H,9,10)
KBio1_000273
KBio2_001001
KBio2_002277
KBio2_003569
KBio2_004845
 
KBio2_006137
KBio2_007413
KBio3_002626
KBio3_002757
KBioGR_000871
KBioGR_002277
KBioSS_001001
KBioSS_002278
Kyselina 2-propylvalerova
Kyselina 2-propylvalerova [Czech]
LS-161170
LS-2068
MLS001076682
MLS001335927
MLS001335928
MLS002415770
Med Valproic
Med valproic
MolPort-001-791-895
Mylproin
Myproate
Myproic Acid
Myproic acid
N-DPA
N-Dipropylacetic acid
NCGC00091149-01
NCGC00091149-02
NCGC00091149-03
NCGC00091149-04
NINDS_000273
NSC 93819
NSC93819
Novo-Valproic
Novo-Valproic - ECC
Novo-divalproex
Novo-valproic
Novo-valproic soft gel cap
Nu-Valproic
Nu-valproic
P0823
P6273_SIGMA
PEAC
PHL-valproate
PHL-valproic acid
PHL-valproic acid E.C.
PMS-Divalproex
PMS-Valproic Acid
PMS-valproate
PMS-valproic acid
PMS-valproic acid E.C.
Penta-Valproic
Penta-valproic
Propylvaleric acid
Ratio-Valproic - ECC
S(-)-4-En-valproate
S(-)-4-En-valproic acid
S-2-N-Propyl-4-pentenoate
S-2-N-Propyl-4-pentenoic acid
SAM002564230
SBB065764
SMR000499581
SPBio_000912
Sandoz valproic
Savicol
Semisodium Valproate
Sodium hydrogen divalproate
Spectrum2_000946
Spectrum3_001733
Spectrum4_000376
Spectrum_000521
Sprinkle
Stavzor
UNII-614OI1Z5WI
VALPROIC ACID
VALPROIC acid
VPA
Valcote
Valparin
Valproate
Valproate Semisodium
Valproate semisodique [French]
Valproate semisodium
Valproato semisodico [Spanish]
Valproatum seminatricum [Latin]
Valproic
Valproic Acid
Valproic Acid, Sodium Salt (2:1)
Valproic acid
Valproic acid (USP)
Valproic acid USP
Valproic acid USP24
Valproic acid [USAN:INN:BAN]
Valproic acid [usan:ban:inn]
Valproinsaeure
Valproinsäure
Vupral
WLN: QVY3 & 3
di-n-propylacetic acid
n-DPA
n-Dipropylacetic acid
nchembio.79-comp4
nchembio815-comp21
valproate
valproic acid
13
Riluzoleapproved, investigationalPhase 2, Phase 3591744-22-55070
Synonyms:
1744-22-5
2-Amino-6-(trifluoromethoxy)-benzothiazole
2-Amino-6-(trifluoromethoxy)benzothiazole
2-Amino-6-trifluoro- methoxybenzothiazole
2-amino-6-(trifluoromethoxy)-1,3-benzothiazole
2-amino-6-(trifluoromethoxy)benzo[d]thiazole
2-amino-6-(trifluoromethoxyl)benzothiazole
2-amino-6-trifluoromethoxybenzothiazole
6-(trifluoromethoxy)-1,3-benzothiazol-2-amine
6-(trifluoromethoxy)benzo[d]thiazol-2-amine
6-Trifluoromethoxy-benzothiazol-2-ylamine
6-trifluoromethoxybenzothiazole-2-yl-amine
AC-730
AC1L1JJL
AC1Q530H
AKOS000265071
ALBB-006046
Amino-2 trifluoromethoxy-6 benzothiazole
Amino-2 trifluoromethoxy-6 benzothiazole [French]
BB_SC-4839
BF-37
BIDD:GT0055
BPBio1_000037
BPBio1_000837
BRD-K21283037-001-02-5
BRD-K21283037-003-03-9
BSPBio_000033
Bio1_000416
Bio1_000905
Bio1_001394
Biomol-NT_000245
C07937
C8H5F3N2OS
CHEMBL744
CID5070
D00775
DB00740
EU-0101064
FT-0082997
HMS1773G08
HMS2089O19
HMS2094G07
I01-2084
LS-40688
 
Lopac-R-116
Lopac0_001064
MLS000069369
MolPort-000-151-262
NCGC00015882-01
NCGC00015882-02
NCGC00015882-03
NCGC00015882-07
NCGC00015882-11
NCGC00023141-02
NCGC00023141-04
NCGC00023141-05
NCGC00023141-06
PK-26124
PK-26124, RP-54274, Rilutek, Riluzole
Prestwick-03A08
Prestwick0_000167
Prestwick1_000167
Prestwick2_000167
Prestwick3_000167
R-116
R116_SIGMA
RP 54274
RP-54274
Rilutek
Rilutek (TN)
Riluzol
Riluzol [INN-Spanish]
Riluzole
Riluzole (JAN/USAN/INN)
Riluzole HCl
Riluzole Hydrochloride
Riluzole [USAN:INN]
Riluzolum
Riluzolum [INN-Latin]
S1614_Selleck
SMR000058231
SPBio_000599
SPBio_001954
STK503686
Spectrum2_000550
Tocris-0768
UNII-7LJ087RS6F
ZERO/001785
ZINC00006481
riluzole
14
DalfampridineapprovedPhase 2, Phase 362504-24-51727
Synonyms:
.gamma.-Aminopyridine
275875_ALDRICH
36687_FLUKA
36687_RIEDEL
4 AP
4 Aminopyridine
4 Aminopyridine Sustained Release
4-AP
4-Aminopyridine
4-Aminopyridine 10
4-Aminopyridine Sustained Release
4-Pyridinamine
4-Pyridylamine
4-aminopyridine
5-22-09-00106 (Beilstein Handbook Reference)
504-24-5
A 0152
A0414
A78403_ALDRICH
AB1004971
AC-907/25014071
AC1L1C3R
AC1Q52BM
AI3-52547
AKOS000119896
Amaya
Amino-4 pyridine
Amino-4-Pyridine
Ampydin
Ampyra
Avitrol
Avitrol 200
BB_SC-6974
BRN 0105782
BSPBio_001562
Bio1_000353
Bio1_000842
Bio1_001331
Bio2_000282
Bio2_000762
C13728
C5H6N2
CHEBI:34385
CHEMBL284348
CID1727
Caswell No. 038
Compound 1861
D015761
D04127
Dalfampridine
DivK1c_000572
EINECS 207-987-9
EL-970
EPA Pesticide Chemical Code 069201
EU-0100032
FT-0083754
Fampridina
Fampridine
Fampridine (USAN/INN)
Fampridine SR
Fampridine [USAN:INN]
Fampridine-PR
Fampridine-SR
Fampridinum
Fampyra
HC150041
HMS1361O04
HMS1791O04
HMS1921H15
HMS1989O04
HMS2092F05
HMS501M14
HSDB 6037
IDI1_000572
IDI1_034032
InChI=1/C5H6N2/c6-5-1-3-7-4-2-5/h1-4H,(H2,6,7
 
KBio1_000572
KBio2_000282
KBio2_000635
KBio2_002850
KBio2_003203
KBio2_005418
KBio2_005771
KBio3_000563
KBio3_000564
KBio3_001888
KBioGR_000282
KBioGR_001505
KBioSS_000282
KBioSS_000635
LS-130202
Lopac-A-0152
Lopac0_000032
MLS000069400
Mi-W-3
MolPort-000-146-022
N07XX07
NCGC00015009-01
NCGC00015009-03
NCGC00015009-12
NCGC00024890-01
NCGC00024890-02
NCGC00024890-03
NCGC00024890-04
NCGC00024890-05
NCGC00024890-06
NCGC00024890-07
NCGC00024890-08
NCGC00024890-09
NCGC00024890-10
NINDS_000572
NSC 15041
NSC15041
Neurelan
Neurelan (TN)
P-Aminopyridine
PYRIDINE,4-AMINO
Philips 1861
Phillips 1861
Pimadin (free base)
Prc 1237
Pymadin
Pymadine
RCRA waste no. P008
SDCCGMLS-0066228.P001
SMR000058211
SPBio_001486
SPECTRUM1501130
STK298717
Spectrum2_001413
Spectrum3_000914
Spectrum4_001013
Spectrum5_001501
Spectrum_000155
Sustained Release, 4-Aminopyridine
TL8003344
Tocris-0940
UNII-BH3B64OKL9
UPCMLD-DP125
UPCMLD-DP125:001
VMI 10-3
VMI 103
VMI-10-3
VMI-103
VMI103
WLN: T6NJ DZ
[J.Pharmacol.Exp.Ther. 275:864 (1995)]
gamma-Aminopyridine
nchem.892-comp4
p-Aminopyridine
p-Aminopyridine [UN2671] [Poison]
p-Aminopyridine [UN2671] [Poison]
pyridin-4-amine
pyridin-4-ylamine
15
HydroxyureaapprovedPhase 2, Phase 3, Phase 1188127-07-13657
Synonyms:
1-HYDROXYUREA
127-07-1
4-03-00-00170 (Beilstein Handbook Reference)
55291_FLUKA
AC1L1GF8
AC1Q4ZXK
AI3-51139
BB_SC-7256
BRN 1741548
BSPBio_002164
Bio1_000451
Bio1_000940
Bio1_001429
Biosupressin
C07044
CCRIS 958
CHEBI:44423
CHEMBL467
CID3657
Carbamohydroxamic Acid
Carbamohydroxamic acid
Carbamohydroximic Acid
Carbamohydroximic acid
Carbamohydroxyamic Acid
Carbamohydroxyamic acid
Carbamoyl Oxime
Carbamoyl oxime
Carbamyl Hydroxamate
Carbamyl hydroxamate
Carrbamoyl Oxime
D00341
D006918
DB01005
DRG-0253
DivK1c_000556
Droxia
Droxia (TM)
Droxia (TN)
E0723DBA-5AF3-49D1-B5F6-59420AB87AC9
EINECS 204-821-7
EU-0100596
FT-0083575
H 8627
H0310
H20210
H8627_SIGMA
HMS1920F09
HMS2091L17
HMS501L18
HSDB 6887
HU
HYDREA (TN)
HYDROXY-UREA
Hidrix
Hidroxicarbamida
Hidroxicarbamida [INN-Spanish]
Hydrea
Hydrea (TM)
Hydrea, Biosupressin, Cytodrox, Hydroxyurea
Hydreia
Hydroxicarbamidum
Hydroxycarbamid
Hydroxycarbamide
Hydroxycarbamide (JAN/INN)
Hydroxycarbamidum
Hydroxycarbamidum [INN-Latin]
Hydroxycarbamine
Hydroxyharnstoff
Hydroxyharnstoff [German]
Hydroxylurea
Hydroxyurea
Hydroxyurea (D4)
Hydroxyurea (USP)
Hydroxyurea [USAN:BAN]
Hydroxyurea(d4)
 
Hydura
Hydurea
I05-0250
IDI1_000556
Idrossicarbamide
Idrossicarbamide [DCIT]
Idrossicarbamide [Dcit]
KBio1_000556
KBio2_001389
KBio2_003957
KBio2_006525
KBio3_001384
KBioGR_000383
KBioSS_001389
LS-709
Litaler
Litalir
Lopac-H-8627
Lopac0_000596
MLS001332381
MLS001332382
MLS002153389
MolMap_000029
MolPort-000-003-971
Mylocel
N-(Aminocarbonyl) Hydroxyamine
N-Carbamoylhydroxylamine
N-HYDROXY UREA
N-Hydroxymocovina
N-Hydroxymocovina [Czech]
N-Hydroxyurea
NCGC00015520-01
NCGC00015520-02
NCGC00015520-07
NCGC00093974-01
NCGC00093974-02
NCGC00093974-03
NCGC00093974-04
NCGC00093974-05
NCI C04831
NCI-C04831
NCI60_002773
NCIMech_000139
NHY
NINDS_000556
NSC 32065
NSC32065
Onco-Carbide
Onco-carbide
Oncocarbide
Oxyurea
S-phase/G-1 interface inhibitor
S1896_Selleck
SK 22591
SMR000059149
SPBio_000247
SPECTRUM1500344
SQ 1089
SQ-1089
Siklos
Spectrum2_000064
Spectrum3_000462
Spectrum4_000012
Spectrum5_000836
Spectrum_000909
Sterile Urea
TL8000673
UNII-X6Q56QN5QC
Ureaphil
WLN: ZVMQ
carbamide oxide
hydroxyaminomethanamide
hydroxyurea
nchembio.573-comp3
nchembio.90-comp4
nchembio749-comp3
tetratogen: inhibits ribonucleoside diphosphate reductase
16Antimanic AgentsPhase 3, Phase 1, Phase 2663
17Central Nervous System DepressantsPhase 3, Phase 1, Phase 210016
18Psychotropic DrugsPhase 3, Phase 1, Phase 25501
19Tranquilizing AgentsPhase 3, Phase 1, Phase 23597
20Protective AgentsPhase 2, Phase 35651
21Excitatory Amino AcidsPhase 2, Phase 31109
22AnticonvulsantsPhase 2, Phase 3, Phase 12249
23Neurotransmitter AgentsPhase 2, Phase 3, Phase 114795
24Contraceptives, OralPhase 2, Phase 33734
25Nucleic Acid Synthesis InhibitorsPhase 2, Phase 3, Phase 13836
26Excitatory Amino Acid AntagonistsPhase 2, Phase 31095
27Potassium Channel BlockersPhase 2, Phase 3151
28Neuroprotective AgentsPhase 2, Phase 31376
29carnitineNutraceuticalPhase 3, Phase 1, Phase 2146
30FlaxNutraceuticalPhase 394
31Omega 3 Fatty AcidNutraceuticalPhase 3912
32
Leuprolideapproved, investigationalPhase 227953714-56-03911, 657181
Synonyms:
(D-Leu(6),des-gly-NH2(10),pro-ethylamide(9))-gonadotropin-releasing hormone
5-oxoPro-His-Trp-Ser-Tyr-D-Leu-Leu-Arg-ProNHC2H5 dihydrate
5-oxoprolylhistidyltryptophylseryltyrosylleucylleucyl-n5-(diaminomethylidene)ornithyl-n-ethylprolinamide
AC1L1GZK
AC1L9B44
AC1Q5OPO
AR-1G9354
C07612
CID3911
CID441410
D00989
D08113
Eligard
Enantone
Enantone (TN)
I04-0109
L-Pyroglutamyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-D-leucyl-L-leucyl-L-arginyl-L-proline ethylamide
L001094
 
L002030
Leuprolide
Leuprolide Acetate
Leuprolide acetate
Leuprolide acetate (USAN)
Leuprorelin
Leuprorelin (INN)
Leuprorelin acetate (JAN)
Leuprorelina
Leuproreline
Leuprorelinum
Lupron
Lupron (TN)
N-[1-[[1-[[1-[[1-[[1-[[1-[[5-(diaminomethylideneamino)-1-[2-(ethylcarbamoyl)pyrrolidin-1-yl]-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide
NSC377526
NSC746847
PGlu-his-trp-ser-tyr-D-leu-leu-arg-pro-NHC2H5
PGlu-his-trp-ser-tyr-D-leu-leu-arg-pro-nhet
acetic acid
leuprolide
33PiracetamPhase 21367491-74-9
34EtiracetamPhase 2196
35Nootropic AgentsPhase 2604
364-phenylbutyric acidPhase 1, Phase 248
37Pharmaceutical SolutionsPhase 2, Phase 17004
38Pyridostigmine BromidePhase 222101-26-8
39Anti-Infective AgentsPhase 2, Phase 117220
40BromidesPhase 2523
41Cholinesterase InhibitorsPhase 2498
42Cholinergic AgentsPhase 23243
43Antiviral AgentsPhase 28071
44Reverse Transcriptase InhibitorsPhase 21656
45Anti-Retroviral AgentsPhase 22794
46
EpicatechinNutraceuticalPhase 1, Phase 261490-46-072276
Synonyms:
(-)-Epicatechin
(-)-Epicatechol
(2R,3R)-(-)-Epicatechin
3,3',4',5,7-Pentahydroxyflavane
Epicatechol
 
Epigallocatechin
L(-)-Epicatechin
L-Acacatechin
L-Epicatechin
L-Epicatechol
alpha-Catechin
47TeaNutraceuticalPhase 1, Phase 2295
48
CatechinNutraceuticalPhase 1, Phase 261154-23-49064
Synonyms:
(+)-Catechin
(+)-Cyanidan-3-ol
(+)-Cyanidanol
(+)-catechin hydrate
(+/-)-Catechin
(+/-)-catechin hydrate
(2R,3S)-(+)-Catechin
(2R,3S)-Catechin
3,3',4',5,7-Flavanpentol
Biocatechin
Catechin
 
Catechinate
Catechinic acid
Catechuate
Catechuic acid
Catergen
Cianidanol
Cianidanolum
Cianidol
Cyanidanol
D-(+)-Catechin
D-Catechin
Trans3,3,4,5,7 pentahydroxyflavane
YK-85 Light Yellow Powder 85
49beta-Hydroxy-beta-methylbutyrateNutraceuticalPhase 215
50
Miconazoleapproved, investigationalPhase 1302622916-47-84189
Synonyms:
(+-)-1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-(2,4-dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl) imidazole
1-[2,4-Dichloro- beta-([2,4-dichloro- benzyl]oxy)phenethyl]imidazole
1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole
1-[2-(2,4-Dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-1H-imidazole
1-[2-(2,4-dichlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole
1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole
1-[2-(2,4-dichlorophenyl)-2-{[(2,4-dichlorophenyl)methyl]oxy}ethyl]-1H-imidazole
1-{2-[(2,4-dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole
22832-87-7 (NITRATE)
22916-47-8
75319-47-0
AB00053500
AC1L1HM1
AKOS001574474
Aflorix(nitrate)
Albistat(nitrate)
Andergin(nitrate)
BPBio1_000279
BRD-A82396632-001-03-0
BRD-A82396632-008-02-7
BRN 0965511
BSPBio_000253
BSPBio_002033
CCRIS 7924
CHEBI:6923
CHEMBL91
CID4189
CPD-4501
Conofite(nitrate)
D00416
DB01110
Dactarin
Daktarin IV
Daktarin iv
Desenex
DivK1c_000156
EINECS 245-324-5
Epi-Monistat(nitrate)
Femizol-M
Florid(nitrate)
Gyno-Daktar(nitrate)
HMS1568M15
HMS2090B21
I14-14342
IDI1_000156
Imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl)methoxy)ethyl)- (9CI)
KBio1_000156
KBio2_001445
KBio2_004013
KBio2_006581
KBio3_001533
KBioGR_000581
KBioSS_001445
LS-78378
Lotrimin AF(nitrate)
MCZ
MJR 1762
MLS002222203
Makesense
Micantin (nitrate)
Micatin
 
Miconasil Nitrate
Miconazol
Miconazol [INN-Spanish]
Miconazole
Miconazole (JP15/USP/INN)
Miconazole 3
Miconazole 3 Combination Pack
Miconazole 7 Combination Pack
Miconazole [USAN:BAN:INN:JAN]
Miconazole nitrate salt
Miconazole-7
Miconazolo
Miconazolo [DCIT]
Miconazolum
Miconazolum [INN-Latin]
Micozole
Minostate
MolPort-002-557-553
Monazole 7
Monista (nitrate)
Monistat
Monistat (TN)
Monistat 1 Combination Pack
Monistat 3 Dual-Pak
Monistat 3 Vaginal Ovules
Monistat 5 Tampon
Monistat 7 Dual-Pak
Monistat 7 Vaginal Suppositories
Monistat Dual- PAK
Monistat IV
Monistat iv (TN)
Monistat iv (tn)
Monistat-Derm
NCI60_001353
NCI60_001380
NINDS_000156
NSC 170986
NSC169434
NSC170986
Novo-Miconazole Vaginal Ovules
Oprea1_091955
Oravig
Prestwick0_000067
Prestwick1_000067
Prestwick2_000067
Prestwick3_000067
Prestwick_335
R 18134
R-14,889
Rash Relief Antifungal
SMR001307249
SPBio_000976
SPBio_002174
STK834405
STOCK1S-93556
Spectrum2_001048
Spectrum3_000507
Spectrum4_000061
Spectrum5_001297
Spectrum_000965
UNII-7NNO0D7S5M
Vusion
Zimycan
imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl) methoxy)ethyl)- (9CI)
miconazole

Interventional clinical trials:

(show top 50)    (show all 148)
idNameStatusNCT IDPhase
1Physiologic Effects of PRMS & Testosterone in the Debilitated ElderlyCompletedNCT00018356Phase 4
2A Trial of Hydroxyurea in Spinal Muscular AtrophyCompletedNCT00485511Phase 2, Phase 3
3Short and Long Term Treatment With 4-AP in Ambulatory SMA PatientsCompletedNCT01645787Phase 2, Phase 3
4Study to Evaluate the Efficacy of Riluzole in Children and Young Adults With Spinal Muscular Atrophy (SMA)CompletedNCT00774423Phase 2, Phase 3
5The Combined Effects of Resistance Training and Flax Oil Supplementation Upon Inflammation in Older AdultsCompletedNCT00465153Phase 3
6Valproate and Levocarnitine in Children With Spinal Muscular AtrophyRecruitingNCT01671384Phase 3
7A Study to Assess the Efficacy and Safety of IONIS-SMN Rx in Infants With Spinal Muscular AtrophyActive, not recruitingNCT02193074Phase 3
8A Study to Assess the Efficacy and Safety of IONIS-SMN Rx in Patients With Later-onset Spinal Muscular AtrophyActive, not recruitingNCT02292537Phase 3
9An Open-Label Study (SHINE) for Patients With Spinal Muscular Atrophy (SMA) Who Participated in Studies With IONIS-SMNRxEnrolling by invitationNCT02594124Phase 3
10CARNIVAL Type I: Valproic Acid and Carnitine in Infants With Spinal Muscular Atrophy (SMA) Type ICompletedNCT00661453Phase 1, Phase 2
11Valproic Acid and Carnitine in Patients With Spinal Muscular AtrophyCompletedNCT00227266Phase 2
12Valproic Acid in Ambulant Adults With Spinal Muscular AtrophyCompletedNCT00481013Phase 2
13Study to Evaluate Sodium Phenylbutyrate in Pre-symptomatic Infants With Spinal Muscular AtrophyCompletedNCT00528268Phase 1, Phase 2
14An Open-label Safety, Tolerability and Dose-range Finding Study of Multiple Doses of ISIS SMNRx in Patient With Spinal Muscular AtrophyCompletedNCT01703988Phase 1, Phase 2
15Study of Safety and Dosing Effect on SMN Levels of Valproic Acid (VPA) in Patients With Spinal Muscular AtrophyCompletedNCT00374075Phase 1, Phase 2
16Levetiracetam for Cramps, Spasticity and Neuroprotection in Motor Neuron DiseaseCompletedNCT00324454Phase 2
17A Pilot Therapeutic Trial Using Hydroxyurea in Type I Spinal Muscular Atrophy PatientsCompletedNCT00568698Phase 1, Phase 2
18Safety and Efficacy of Olesoxime (TRO19622) in 3-25 Years SMA Patients.CompletedNCT01302600Phase 2
19Pilot Study of Growth Hormon to Treat SMA Typ II and IIICompletedNCT00533221Phase 2
20Phase II Study of Leuprolide and Testosterone for Men With Kennedy's Disease or Other Motor Neuron DiseaseCompletedNCT00004771Phase 2
21Effects of Power Mobility on Young Children With Severe Motor ImpairmentsCompletedNCT01028833Phase 2
22Investigating Modes of Progressive MobilityCompletedNCT00787098Phase 2
23Effect of Functional Exercise in Patients With Spinal Bulbar Muscular AtrophyCompletedNCT01369901Phase 1, Phase 2
24Musculoskeletal Effects of BicarbonateCompletedNCT01475214Phase 2
25Treatment of Dysphagia in Oculopharyngeal Muscular Dystrophy by Autologous Transplantation of MyoblastsCompletedNCT00773227Phase 2
26A Phase 2 Study to Evaluate the Dose and Pharmacodynamic Efficacy of Sialic Acid-Extended Release (SA-ER) Tablets in Patients With GNE Myopathy or Hereditary Inclusion Body MyopathyCompletedNCT01517880Phase 2
27Safety and Efficacy Study of Pyridostigmine on Patients With Spinal Muscular Atrophy Type 3RecruitingNCT02227823Phase 2
28A Study of Multiple Doses of ISIS SMNRx (ISIS 396443) Delivered to Infants With Genetically Diagnosed and Presymptomatic Spinal Muscular AtrophyRecruitingNCT02386553Phase 2
29A Study of CK-2127107 in Patients With Spinal Muscular AtrophyRecruitingNCT02644668Phase 2
30A Study to Evaluate Long Term Safety, Tolerability, and Effectiveness of Olesoxime in Patients With Spinal Muscular AtrophyRecruitingNCT02628743Phase 2
31Safety and Tolerability of Anakinra in Combination With Riluzol in Amyotrophic Lateral SclerosisRecruitingNCT01277315Phase 2
32Transcranial Direct Current Stimulation as a Novel Therapeutic Approach in Amyotrophic Lateral SclerosisRecruitingNCT01569958Phase 2
33Use of (-)-Epicatechin in the Treatment of Becker Muscular Dystrophy (Pilot Study)RecruitingNCT01856868Phase 1, Phase 2
34Efficacy of Umbilical Cord Mesenchymal Stem Cells in Duchenne Muscular DystrophyRecruitingNCT02285673Phase 1, Phase 2
35Task-oriented Upper Limb Training in MSRecruitingNCT02688231Phase 2
36A Study to Assess the Efficacy, Safety and Pharmacokinetics of IONIS SMNRx in Infants With Spinal Muscular AtrophyActive, not recruitingNCT01839656Phase 2
37A Study to Assess the Safety and Tolerability of ISIS 396443 (ISIS SMNRx) in Participants With Spinal Muscular Atrophy (SMA).Active, not recruitingNCT02462759Phase 2
38An Open Label Study of LMI070 in Type 1 Spinal Muscular Atrophy (SMA)Active, not recruitingNCT02268552Phase 1, Phase 2
39A Pilot Therapeutic Trial Using Hydroxyurea in Type II and Type III Spinal Muscular Atrophy PatientsActive, not recruitingNCT00568802Phase 1, Phase 2
40Ghrelin Plus Strength Training in Frail Elderly StudyActive, not recruitingNCT01898611Phase 2
41Observational Study of Fat Loss in HIV Infected Adults Taking Nucleoside Reverse Transcriptase Inhibitors (NRTIs)Active, not recruitingNCT00119405Phase 2
42Postacute Sarcopenia: Supplementation With β-hydroxyMethylbutyrate After Resistance TrainingNot yet recruitingNCT02679742Phase 2
43Clinical Trial of Sodium Phenylbutyrate in Children With Spinal Muscular Atrophy Types II or IIITerminatedNCT00439569Phase 1, Phase 2
44Clinical Trial of Sodium Phenylbutyrate in Children With Spinal Muscular Atrophy Type ITerminatedNCT00439218Phase 1, Phase 2
45A Trial of Chronotherapy of Corticosteroids in Duchenne Muscular DystrophyWithdrawnNCT02036463Phase 2
46An Open-label Safety, Tolerability, and Dose-range Finding Study of ISIS SMNRx in Patients With Spinal Muscular AtrophyCompletedNCT01494701Phase 1
47An Open-label Safety and Tolerability Study of ISIS SMNRx in Patients With Spinal Muscular Atrophy Who Previously Participated in ISIS 396443-CS1CompletedNCT01780246Phase 1
48Intrathecal Transplantation of Mesenchymal Stem Cell in Patients With ALSCompletedNCT01771640Phase 1
49Intravenous Transplantation of Mesenchymal Stem Cell in Patients With ALSCompletedNCT01759797Phase 1
50Safety Study of Mini-dystrophin Gene to Treat Duchenne Muscular DystrophyCompletedNCT00428935Phase 1

Search NIH Clinical Center for Progressive Muscular Atrophy

Genetic Tests for Progressive Muscular Atrophy

About this section

Anatomical Context for Progressive Muscular Atrophy

About this section

MalaCards organs/tissues related to Progressive Muscular Atrophy:

33
Testes, Liver, Skeletal muscle, Bone, Breast, Spinal cord, Brain

Animal Models for Progressive Muscular Atrophy or affiliated genes

About this section

MGI Mouse Phenotypes related to Progressive Muscular Atrophy:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053888.8AIRE, LMNB1, SMN2, TRPV4
2MP:00030128.3AIRE, C9orf72, SMN2, TARDBP
3MP:00053698.1CAV3, LMNB1, SMN2, TARDBP, TRPV4
4MP:00036317.2AIRE, C9orf72, LMNB1, SMN2, TARDBP, TRPV4
5MP:00053846.8AIRE, C9orf72, CAV3, LMNB1, SMN2, TARDBP

Publications for Progressive Muscular Atrophy

About this section

Articles related to Progressive Muscular Atrophy:

(show top 50)    (show all 88)
idTitleAuthorsYear
1
Periocular dirofilariasis: A case series. (26819190)
2016
2
A small molecule mitigates hearing loss in a mouse model of Usher syndrome III. (27110679)
2016
3
Paraoxonase 1 genotype-phenotype correlation in patients with metabolic syndrome. (26193203)
2015
4
Diagnosis and resolution of LAPeffler endocarditis secondary to eosinophilic granulomatosis with polyangiitis demonstrated by cardiac magnetic resonance-T2 mapping. (25561476)
2015
5
Abscess resulting from Mycobacterium kansasii in the left thigh of AIDS patient. (24937823)
2014
6
Hope abandoned: memantine therapy in frontotemporal dementia. (23305744)
2013
7
EMT and CSC-like properties mediated by the IKKI^/II_BI+/RelA signal pathway via the transcriptional regulator, Snail, are involved in the arsenite-induced neoplastic transformation of human keratinocytes. (23069812)
2013
8
Human blood analysis reveals differences in gene expression of catecholamine-regulated protein 40 (CRP40) in schizophrenia. (23182727)
2013
9
Two-year follow-up of a randomized trial of spectacles plus alternate-day patching to treat strabismic amblyopia. (22998746)
2013
10
Reversible focal encephalic abnormalities in a patient with Guillain-BarrAc syndrome. (22699548)
2012
11
Interweaving microRNAs and proinflammatory cytokines in gastric mucosa with reference to H. pylori infection. (22161133)
2012
12
Type of health insurance and the substance abuse treatment gap. (22119184)
2012
13
NEK7 is essential for centriole duplication and centrosomal accumulation of pericentriolar material proteins in interphase cells. (22100915)
2011
14
Determining the association between preoperative computed tomography findings and postoperative outcomes after cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei. (21207170)
2011
15
A systematic review and meta-analysis of perinatal variables in relation to the risk of testicular cancer--experiences of the son. (20660640)
2010
16
Corticosteroids in the treatment of vestibular neuritis: a systematic review and meta-analysis. (20009780)
2010
17
Association of inflammation with worsening HOMA-insulin resistance. (19680627)
2009
18
Evidence-based emergency medicine/rational clinical examination abstract. Does this patient with a pericardial effusion have cardiac tamponade? (19231666)
2009
19
Current concepts in the management of hepatopulmonary syndrome. (19183751)
2008
20
DNA double-strand break and chromosomal rejoining defects with misrejoining in Nijmegen breakage syndrome cells. (17919995)
2008
21
Contractile effects of 5-hydroxytryptamine (5-HT) in the equine jejunum circular muscle: functional and immunohistochemical identification of a 5-HT1A-like receptor. (18267888)
2008
22
Synthesis, characterization, and evaluation of a novel 99mTc(CO)3 pyrazolyl conjugate of a peptide nucleic acid sequence. (18777182)
2008
23
Postlaminectomy kyphosis in an achondroplastic adolescent treated for spinal stenosis. (19292200)
2008
24
Hypoxia-induced cell death of HepG2 cells involves a necrotic cell death mediated by calpain. (17195093)
2007
25
Primary mucinous adenocarcinoma of the bladder with signet-ring cells: case report. (18094900)
2007
26
Generalized epilepsy with febrile seizures plus-associated sodium channel beta1 subunit mutations severely reduce beta subunit-mediated modulation of sodium channel function. (17629415)
2007
27
Gefitinib and bicalutamide show synergistic effects in primary cultures of prostate cancer derived from androgen-dependent naive patients. (17914592)
2007
28
Treatment of cystoid macular edema in retinitis pigmentosa with intravitreal triamcinolone. (17562986)
2007
29
SUMO4 and MAP3K7IP2 single nucleotide polymorphisms and susceptibility to rheumatoid arthritis. (16755651)
2006
30
Proepithelin promotes migration and invasion of 5637 bladder cancer cells through the activation of ERK1/2 and the formation of a paxillin/FAK/ERK complex. (16849556)
2006
31
Cecal web causing neonatal intestinal obstruction. (17090861)
2006
32
Influence of warfarin therapy on activated factor VII clotting activity. (16575262)
2006
33
Heart-directed expression of a human cardiac isoform of cAMP-response element modulator in transgenic mice. (15569686)
2005
34
Effects of peptide molecular mass and PEG chain length on the vasoreactivity of VIP and PACAP(1-38) in pegylated phospholipid micelles. (15350692)
2004
35
Comprehensive molecular screening of the FBN1 gene favors locus homogeneity of classical Marfan syndrome. (15241795)
2004
36
Priapism in a patient with unstable hemoglobin: hemoglobin KAPln. (12949895)
2003
37
The Cdc42 target ACK2 interacts with sorting nexin 9 (SH3PX1) to regulate epidermal growth factor receptor degradation. (11799118)
2002
38
Effects of nociceptin and endomorphin 1 on the electrically stimulated human vas deferens. (11318773)
2001
39
Polymorphism of the IL1RN gene in Spanish patients with ulcerative colitis]. (10422059)
1999
40
Flow cytometric quantification of HIV-1 Tat protein in tat-transfected Jurkat T cell lines. (9894902)
1998
41
Transcriptional regulation of fibroblast growth factor-2 expression in human astrocytes: implications for cell plasticity. (9693381)
1998
42
Cellular targets for activation by c-Myc include the DNA metabolism enzyme thymidine kinase. (9212167)
1997
43
Neurofibroma of the esophagus. (9354553)
1997
44
Thymidylate synthase mRNA level in adenocarcinoma of the stomach: a predictor for primary tumor response and overall survival. (8558194)
1996
45
Trigger thumb in children: an acute presentation. (7921570)
1994
46
Purification of human thioredoxin reductase: properties and characterization by absorption and circular dichroism spectroscopy. (8343516)
1993
47
Morphological approaches to the prenatal diagnosis of late-infantile and juvenile Batten disease. (8411995)
1993
48
Effects of single doses of quinapril and atenolol on autonomic nervous function and exercise capacity in healthy volunteers. (2197098)
1990
49
Struma ovarii. (14922286)
1952
50
Erythema nodosum; the provocation phenomenon; with special reference to lymphogranuloma venereum (Nicolas-Favre). (14778345)
1950

Variations for Progressive Muscular Atrophy

About this section

Expression for genes affiliated with Progressive Muscular Atrophy

About this section
Search GEO for disease gene expression data for Progressive Muscular Atrophy.

Pathways for genes affiliated with Progressive Muscular Atrophy

About this section

GO Terms for genes affiliated with Progressive Muscular Atrophy

About this section

Cellular components related to Progressive Muscular Atrophy according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1Cajal bodyGO:00150309.7SMN1, SMN2
2cytoplasmic ribonucleoprotein granuleGO:00364649.7SMN1, SMN2
3perikaryonGO:00432049.4SMN1, SMN2

Biological processes related to Progressive Muscular Atrophy according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1nuclear importGO:005117010.2SMN1, SMN2
2spliceosomal snRNP assemblyGO:00003879.8SMN1, SMN2
3positive regulation of cytosolic calcium ion concentrationGO:00072049.6CAV3, TRPV4
4spliceosomal complex assemblyGO:00002459.4SMN1, SMN2

Sources for Progressive Muscular Atrophy

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet